Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade · PMID 42321916
View analysis →A grade · PMID 42372741
View analysis →A grade · PMID 42382416
View analysis →A grade · PMID 42150584
View analysis →This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 80.2/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 46.0; sample size: 40.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 80.2/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 76.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 80.1/100. Study design: 80.0; human relevance: 95.0; therapeutic relevance: 75.4; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 80.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 55.2; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 80.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 70.2; sample size: 70.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 80.0/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 10.0; sample size: 80.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 80.0/100. Study design: 100.0; human relevance: 75.0; therapeutic relevance: 40.0; sample size: 70.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 80.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 87.3; sample size: 50.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.8/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 54.2; sample size: 70.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.8/100. Study design: 100.0; human relevance: 75.0; therapeutic relevance: 51.7; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.8/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 84.2; sample size: 40.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.8/100. Study design: 80.0; human relevance: 95.0; therapeutic relevance: 63.8; sample size: 40.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.7/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 26.2; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.7/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 58.6; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.7/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 51.0; sample size: 40.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.6/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 78.2; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.6/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 53.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.6/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 38.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.5/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 72.5; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 79.4/100. Study design: 100.0; human relevance: 75.0; therapeutic relevance: 42.2; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
